Patents by Inventor Steve White

Steve White has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050198530
    Abstract: Methods and apparatus for automated adaptive reprovisioning of servers under security assault. The method comprises detecting a security assault or a possible security assault on a first server, and reprovisioning by automatically creating a new server instance with a desired new server configuration to perform at least one of the tasks performed by said server.
    Type: Application
    Filed: December 12, 2003
    Publication date: September 8, 2005
    Inventors: David Chess, Prashant Pandey, Ian Whalley, Steve White
  • Publication number: 20050183393
    Abstract: A dispensing apparatus is provided suitable for dispensing at least first and second components in desired ratios especially for multi-component packaged food products. The apparatus comprises a hopper having an outlet at its lower end and a first auger having a hollow shaft disposed within the hopper having component conveying flights and a drive means for rotating the auger. A first component is conveyed by the auger flights and dispensed at an outlet while a second component is conveyed though a hollow shaft of the auger. The apparatus can include a second rotationally driven auger that is positioned within the hollow shaft of the first auger having conveying flights. The second component can be conveyed via the second auger within the hollow shaft. The second auger's shaft also can be hollow whereby a third component can be conveyed through the second hollow shaft of the second auger.
    Type: Application
    Filed: April 28, 2005
    Publication date: August 25, 2005
    Inventors: Michael Engesser, Andrew Peterson, Steve White
  • Patent number: 6794187
    Abstract: The present invention relates to a novel gene which is associated with audiogenic seizures in mice. The gene is known as the Monogenic Audiogenic Seizure-susceptible gene or mass1. The product of the mass1 gene is designated MASS1. Nucleic acid molecules that encode for MASS1 have been identified and purified. The sequence of murine mass1 can be found at SEQ ID NO: 1, and the sequence of human mass1 can be found at SEQ ID NO: 3. Mammalian genes encoding a MASS1 protein are also provided. The invention also provides recombinant vectors comprising nucleic acid molecules that code for a MASS1 protein. These vectors can be plasmids. In certain embodiments, the vectors are prokaryotic or eukaryotic expression vectors. The nucleic acid coding for MASS1 can be linked to a heterologous promoter. The invention also relates to transgenic animals in which one or both alleles of the endogenous mass1 gene is mutated.
    Type: Grant
    Filed: September 3, 2002
    Date of Patent: September 21, 2004
    Assignee: University of Utah Research Foundation
    Inventors: Louis J. Ptacek, H. Steve White, Ying-Hui Fu, Shana Skradski
  • Publication number: 20030226154
    Abstract: The present invention relates to a novel gene which is associated with audiogenic seizures in mice. The gene is known as the Monogenic Audiogenic Seizure-susceptible gene or mass1. The product of the mass1 gene is designated MASS1. Nucleic acid molecules that encode for MASS I have been identified and purified. The sequence of murine mass1 can be found at SEQ ID NO: 1, and the sequence of human mass1 can be found at SEQ ID NO: 3. Mammalian genes encoding a MASS1 protein are also provided. The invention also provides recombinant vectors comprising nucleic acid molecules that code for a MASS1 protein. These vectors can be plasmids. In certain embodiments, the vectors are prokaryotic or eukaryotic expression vectors. The nucleic acid coding for MASS1 can be linked to a heterologous promoter. The invention also relates to transgenic animals in which one or both alleles of the endogenous mass1 gene is mutated. The invention further relates to a hearing impairment associated with the Frings MASS1 mutation.
    Type: Application
    Filed: April 25, 2003
    Publication date: December 4, 2003
    Inventors: Brian Klein, H. Steve White, Louis Ptacek
  • Publication number: 20030208782
    Abstract: The present invention relates to a novel gene which is associated with audiogenic seizures in mice. The gene is known as the Monogenic Audiogenic Seizure-susceptible gene or mass1. The product of the mass1 gene is designated MASS1. Nucleic acid molecules that encode for MASS1 have been identified and purified. The sequence of murine mass1 can be found at SEQ ID NO: 1, and the sequence of human mass1 can be found at SEQ ID NO: 3. Mammalian genes encoding a MASS1 protein are also provided. The invention also provides recombinant vectors comprising nucleic acid molecules that code for a MASS1 protein. These vectors can be plasmids. In certain embodiments, the vectors are prokaryotic or eukaryotic expression vectors. The nucleic acid coding for MASS1 can be linked to a heterologous promoter. The invention also relates to transgenic animals in which one or both alleles of the endogenous mass1 gene is mutated.
    Type: Application
    Filed: September 3, 2002
    Publication date: November 6, 2003
    Inventors: Louis J. Ptacek, H. Steve White, Ying-Hui Fu, Shana Skradski
  • Patent number: 6610883
    Abstract: Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, pyrrole, and polyenoic acid derivatives including carbocyclic polyenoic acids. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.
    Type: Grant
    Filed: July 13, 1998
    Date of Patent: August 26, 2003
    Assignee: Ligand Pharmaceuticals, Inc.
    Inventors: Marcus F. Boehm, Richard A. Heyman, Lin Zhi, Chan Kou (Jack) Hwang, Steve White, Alex Nadzan
  • Patent number: 5780676
    Abstract: Compounds, compositions, and methods for modulating processes mediated by Retinoid X Receptors using retinoid-like compounds which have activity selective for members of the subclass of Retinoid X Receptors (RXRs), in preference to members of the subclass of Retinoic Acid Receptors (RARs). Examples of such compounds are bicyclic benzyl, pyridinyl, thiophene, furanyl, pyrrole, and poiyenoic acid derivatives including carbocyclic polyenoic acids. The disclosed methods employ compounds for modulating processes selectively mediated by Retinoid X Receptors.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 14, 1998
    Assignee: Ligand Pharmaceuticals Incorporated
    Inventors: Marcus F. Boehm, Richard A. Heyman, Lin Zhi, Chan Kou Hwang, Steve White, Alex Nadzan
  • Patent number: 5305834
    Abstract: A rock gathering tool (10) for collecting rocks and stones lying on or loosely embedded in the surface of the ground, comprising a rock collection basket having an opening (19) at its front side, a handle (27) fixedly mounted to the basket and extending forwardly of the basket for pulling the basket along the surface of the ground, a plurality of tines (29) mounted to the basket along the bottom edge at the front side of the basket, the plurality of tines extending forwardly of and downwardly from the basket, and a one-way gate (36) for closing the opening at the front side of the basket and which is pivotable inwardly of the basket to allow rocks and stones to enter the basket as the basket is pulled along the ground.
    Type: Grant
    Filed: January 8, 1993
    Date of Patent: April 26, 1994
    Inventor: Steve White